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Summary
The search for general strategies for inhibiting protein-
protein interactions has been stimulated by recogni-
tion of the key role they play in virtually every process
of living systems. Multiprotein complex assembly and
localization by PDZ domain-containing proteins exem-
plify processes critical to cell physiology and function
that are mediated by b strand association. Here we
describe the development of substituted ‘‘@-tides,’’
protease-resistant peptidomimetics incorporating con-
formationally restricted amino acid surrogates that re-
produce the hydrogen-bonding pattern and side-chain
functionality of a b strand. The synthetic flexibility and
generality of the substituted @-tide design was demon-
strated by the synthesis of a panel of ligands for the
a1-syntrophin PDZ domain. The rational design of a
small molecule of unprecedented affinity for the PDZ
domain suggests that these peptidomimetics may pro-
vide a general method for inhibiting protein-protein
interactions involving extended peptide chains.
Introduction
PDZ protein-interaction domains play a central role in a
host of diverse cellular processes involving the assem-
bly and localization of multiprotein complexes [1–3].
First discovered as the scaffolding component in synap-
tic signaling complexes and tight-junction assemblies,
they have been identified as the recognition element in
a variety of other membrane assemblies, in protein traf-
ficking networks, and in intracellular housekeeping pro-
teases [4]. The critical role played by PDZ domains in
cellular interactions has recently been underscored by
the implication that virulence of avian and human influ-
enza strains is dictated by the spectrum of PDZ binding
by viral NS1 protein [5].
PDZ domains are characterized by a cleft between an
a helix and a flanking b sheet that binds a protein ligand
by capturing its C-terminal tail as an extension of the
b sheet (Figures 1A and 1B). Ligand specificity is thus
conferred by the sequence of this C-terminal peptide,
which enables the PDZ domain to bind a variety of part-
ners independently of their overall tertiary structures.
Measured dissociation constants for PDZ domain-
ligand interactions are typically in the low micromolar
*Correspondence: paul_bartlett@berkeley.edurange [6]. To date, most efforts to understand the bind-
ing properties of PDZ domains have probed sequence
selectivity within peptide ligands. Library screening
[7–9] and phage selection [10, 11] have demonstrated
that sequences with higher affinity than the ‘‘natural’’
partner can be identified, and conformational constraint
via side chain-side chain cyclization has led to improved
binding of short peptides [12, 13]. The defined cleft in
which the PDZ domain binds its ligand and the modest
affinity of the complex make this protein-protein interac-
tion potentially amenable to small-molecule inhibition
[14], and, indeed, structure- and NMR-based library
screening has resulted in the discovery of some non-
peptidic inhibitors of PDZ domains [15–17].
Protein-protein interactions mediated by b strand as-
sociation, as exemplified by the PDZ domain motif, offer
many opportunities for therapeutic intervention but re-
main elusive targets for drug discovery. The common
feature of these interactions suggests that b strand mim-
icry could serve as a general strategy for the design of
competitive ligands for these protein binding sites. The
challenge in designing a b strand peptidomimetic is to
induce the extended conformation and maintain the hy-
drogen-bonding pattern of the peptide backbone, as
well as to enable the incorporation of functionalized
side chains. Designs in which covalent side chain-side
chain linkages embed the peptide in a macrocyclic
framework [18] or in which portions of the peptide back-
bone are replaced with rigid heterocyclic structures [19,
20] achieve these goals with varying degrees of success
and differ considerably in synthetic accessibility. In this
report, we present the development of the ‘‘aza-@-unit,’’
2 (Figure 1C), as a module in protease-resistant b strand
mimics and describe ligands for the PDZ domain of
a1-syntrophin that are significantly more potent than
the corresponding peptide sequences. Since the side
chains of this modular unit are incorporated from amino
acids, this approach can potentially be applied to any
peptide sequence.
Results and Discussion
Design and Synthesis of Substituted @-Tides
The 4,5-dihydro-2(3H)-pyrazinone moiety, 2, is an en-
hanced design relative to the previously described
1,2-dihydro-3(6H)-pyridinone derivative 1 (the ‘‘@-unit’’)
[20, 21]. Both amino acid surrogates have a cyclic struc-
ture that stabilizes the extended conformation and,
when incorporated at alternating positions in a b strand
peptidomimetic, also maintains a canonical hydrogen
bonding pattern along one edge. We have shown previ-
ously that the simple @-unit is exceptionally effective as
a stabilizing template for b-hairpin structures in aqueous
solution [22]. The cyclic @-unit is easily synthesized and
incorporated in oligomeric peptidomimetics, termed
‘‘@-tides’’ [20], but its design makes the regio- and ster-
eoselective introduction of side chains difficult. The new
aza-@-unit retains the conformational and hydrogen-
bonding advantages of the original monomer and,
furthermore, enables straightforward incorporation of
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on the substituted analogs can engage a peptide or the
edge of a b sheet using the full complement of noncova-
lent interactions found in a natural b strand (Figure 1C).
To evaluate the efficacy and generality of this design,
we synthesized a series of @-tides targeted to the PDZ
domain of a1-syntrophin, based on the structure of
this protein bound to a heptapeptide ligand [8]. This rep-
resentative PDZ motif was chosen because it has been
well characterized structurally and for its ability to bind
short peptides with micromolar affinity [8]. a1-Syntro-
phin, a membrane-bound scaffolding protein responsi-
ble for organization of the neuromuscular junction [23],
binds a variety of important protein partners through
its PDZ domain, including voltage-gated sodium chan-
nels [8], neuronal nitric oxide synthase (nNOS) [23, 24],
Figure 1. Extended Conformations of PDZ Ligands and @-Tides
(A) Ribbon representation of GVKESLV (green) bound to the PDZ
domain of a1-syntrophin (blue).
(B) Extended conformation of the C-terminal residues of the bound
peptide (both images generated from conformer 1 of 2PDZ [8]).
(C) Comparison of the unsubstituted @-unit and substituted aza-@-
unit incorporated into a peptidomimetic.ATP binding cassette transporter (ABCA1) [25], and
the a1D subtype of adrenergic receptor (AR) [26]. The li-
gand consensus sequence was deduced to be (K/R)24-
E23-(S/T)22-X21-V0, with no preference past the 24 po-
sition (following the conventional numbering system for
PDZ ligands) [1]. In common with all PDZ-ligand interac-
tions, the structure of the complex of a1-syntrophin with
GVKESLV shows the backbone of the peptide to be hy-
drogen-bonded to the PDZ cleft at the 0,22, and24 po-
sitions (Val, Ser, and Lys), leaving the NH and C=O moi-
eties at 21 and 23 (Leu and Glu) facing the exterior
(Figure 1B) [8]. Thus, the glutamate and leucine residues
in the peptide were the logical positions to explore the
effect of @-unit replacements. To deconvolute the effect
of conformational preorganization from loss of the side
chain with the unsubstituted @-unit, we also included
in our study peptides in which those residues were re-
placed with glycine or sarcosine.
The @Leu and @Glu monomers (the superscript desig-
nates the amino acid side chain on the aza-@-unit) for
the construction of substituted @-tides are synthesized
as cyclic monothioimides from amino acid precursors
with appropriate side chain protection (Figure 2). Most
conveniently, N-terminal nitrogens are protected as
Cbz-derivatives, and side chains are protected with
acid labile groups. Activation of the thioimide for cou-
pling is accomplished by S-methylation with an excess
of methyl iodide and one equivalent of a tertiary amine
base; more strongly basic conditions lead to deprotona-
tion at the a position and tautomerization to the unreac-
tive, achiral 3,4-dihydro-2(1H)-pyrazinone. The resulting
acylthioimidate couples to a peptidyl amino group in
acetonitrile in the presence of ytterbium triflate as
a Lewis acid catalyst, which improves dramatically the
coupling efficiency and stereoretention in the 1,4-addi-
tion reaction. This catalyst also suppresses ring opening
from 1,2-addition, which was observed in some cou-
pling reactions. Once generated, the acyl amidine moi-
ety that forms the conjugated backbone of the aza-@-
unit is stable toward nonaqueous acid and base, as
well as hydrogenolysis, and it is no longer susceptible
to base-catalyzed tautomerization. Deprotection of the
secondary amine, conventional peptide coupling, fol-
lowed by repetition of the thioimide-activation and -addi-
tion steps, enables a complex peptidomimetic to be built
up with alternating amino acids and aza-@-units. The
modular nature of the peptidomimetic allows this syn-
thesis to be adapted to oligomers of varying sequence
and length, similar in concept to peptide synthesis.
Synthesis of KESLV peptidomimetics with @Glu at
the23 position was complicated by the nucleophilic na-
ture of the Ser residue at the adjacent 22 position: de-
protection of the serine hydroxyl under strongly acidic
conditions (e.g., for removal of the t-butyl ether) causes
ring opening of the dihydropyrazinone. Simple inversion
of the protection strategy was stymied by the suscepti-
bility of the benzyl ester of the @Glu side chain to cyclize
to the lactam after deprotection of the secondary amine.
An efficient alternative to acid-labile protecting groups
for serine proved to be the benzyl ether. An adaptation
of Sajiki’s method for selective removal of benzyl carba-
mates effects deprotection of the N-Cbz groups while
preserving the benzyl ether [27]. Final side chain depro-
tection after assembly of the peptidomimetic is carried
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with neat, anhydrous trifluoroacetic acid, followed by
hydrogenolysis of the serine benzyl ether. Although
some epimerization at the @Glu position was observed
after treatment with strong acid (3:1 mixture of S/R iso-
mers), the diastereomers could be separated on TEA-
buffered reverse-phase HPLC. The complete synthesis
for Ac-K@ES@LV is described in the Supplemental
Data (available with this article online).
Stability of Substituted @-Tides
To determine if the acyl amidine linkage of substituted
@-tides is sufficiently robust to permit their use in bio-
logical applications, the stability of several derivatives
was evaluated in aqueous phosphate buffer at pH 4, 7,
and 10. Hydrolysis of the aza-@-unit results in loss of
absorbance at 250 nm, which was monitored by UV
Figure 2. General Scheme for Synthesis of the Aza-@-Unit and
Incorporation into a Peptidomimetic; Chemical Structures of
Ac-K@ESLV and Ac-K@ES@LVspectroscopy. Ac-K@ESLV was compared to the analog
Ac-K@ES(Bn)LV, which retains the serine benzyl ether,
and the trimer Ac-K@LV, in which the aza-@-unit is adja-
cent to a C-terminal carboxyl group.
The acyl amidine linkage is relatively stable in neutral
or basic buffers, although labile under acidic conditions
(Table 1). In neat trifluoroacetic acid, Ac-K@LV un-
dergoes cleavage of the exocyclic C-N bond to give
the cyclic imide, as detected by LC-MS analysis. In con-
trast, treatment of Ac-K@ESLV with TFA followed by ex-
posure to water results in cleavage of the endocyclic
C-N bond, as indicated by formation of an M+18 product
that lacks the acyl amidine chromophore. The mecha-
nism of this cleavage may involve transient formation
of an oxazoline intermediate from attack of the serine
hydroxyl, since the analogous product is not observed
for Ac-K@ES(Bn)LV, in which this side chain is protected.
However, the similar rates at which the various @-tides
undergo hydrolysis under aqueous acidic conditions
suggests that all three compounds undergo hydrolysis
by direct cleavage of the exocyclic C-N bond, without
a significant role for proximal side chain hydroxyl or
terminal carboxyl groups.
In addition to conformational control, one of the key
motivations for utilizing a peptidomimetic is to reduce
the vulnerability of the ligand toward proteolytic en-
zymes. We expected that the pyrazinone-based aza-
@-unit would not fit into a protease active site because
the acyl amidine linkage is so different sterically and
electronically from the peptide linkage. These expecta-
tions were probed by determining the susceptibility of
Ac-K@LV toward cleavage by trypsin and carboxypepti-
dase A, in comparison to the corresponding peptide
Ac-KLV. Trypsin is specific for peptide bonds at the car-
boxyl side of cationic amino acids (e.g., the Lys-Leu link-
age), and carboxypeptidase A is specific for cleavage of
C-terminal hydrophobic amino acids (e.g., the Leu-Val
linkage). Their effects on the tripeptide Ac-KLV and the
peptidomimetic Ac-K@LV were monitored by HPLC.
While both enzymes degraded the peptide rapidly, nei-
ther had any effect on the substituted @-tide over a
24 hr period. The aza-@-unit is thus inert to proteolysis
at both the acyl amidine linkage as well as the tertiary
amide.
Binding of Substituted @-Tides
to the a1-Syntrophin PDZ Domain
The conformational restriction afforded by the @-tide
peptidomimetics enhances their binding to the a1-syn-
trophin PDZ domain significantly relative to unsubsti-
tuted comparison peptides (Table 2). Remarkably, in-
corporation of @Glu in place of Glu at the 23 position in
Ac-KESLV increases the affinity 20-fold (entries 9 versus
1), resulting in the most potent ligand yet characterized
for this protein target. The a1-syntrophin PDZ domain is
known to be selective for peptides with the glutamate
side chain in the 23 position, as well as more tolerant
of variation at the 21 position. This selectivity can also
be seen for the peptides and peptidomimetics of Table
2 as well. Whereas replacement of Glu with sarcosine
abolishes binding within the range of the assay (entry
7), only a 10-fold loss in affinity results from substitution
of the Leu residue with glycine or sarcosine (entries 2
and 3). The conformational constraint provided by the
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loss in binding affinity from absence of the side chain
at the 21 position (entry 4), but not at the 23 position
(entry 8).
Additional positional effects were observed with the
substituted @-tide ligands. Incorporation of the aza-@-
unit is most effective at the glutamate position, where
the peptidomimetic constrains the backbone to a con-
formation similar to that of the bound peptide. The ad-
vantage is less significant at the 21 position where the
Leu residue adopts a more twisted conformation in the
binding site: on replacement with @Leu, the affinity is
maintained (entry 6 versus entry 1) or slightly decreased
(entry 10 versus entry 9). The disparate effects of rigidi-
fying different segments of the backbone in these pepti-
Table 1. Half-Lives of Substituted @-Tides in Aqueous Solution at
20C
10 mM Phosphate Buffer
Conditions: 0.1% TFA pH 4.0 pH 7.0 pH 10.0
Ac-K@ESLV 28 min 4 days 11 days 6 days
Ac-K@ES(Bn)LV 31 min 4 days 23 days 15 days
Ac-K@LV 29 min 2 days 15 days 12 days
Hydrolysis of the aza-@-unit was monitored by the change in UV ab-
sorbance (lmax = 250 nm) at compound concentrations ofw0.2–0.3
mM. The hydrolysis reactions were analyzed as irreversible pro-
cesses to determine the average half-life for each compound [30].
Table 2. Binding of Peptides and @-Tides to a1-Syntrophin PDZ
Domain
Replacement Entry Liganda Kd (mM)
b
Kd/Kd
(peptide)
[Parent peptide] 1 Ac-K-E-S-L-V 6.4 6 0.6 (1)
21 position 2 Ac-KES-Gly-V 70 6 6 11
3 Ac-KES-Sar-V 61 6 4 9.5
4 Ac-KES-@-V 15 6 2 2.3
5 Ac-KES-@
DL -Vc >100 >15
6 Ac-KES-@L-V 7.7 6 0.4 1.2
23 position 7 Ac-K-Sar-SLV >100 >15
8 Ac-K-@-SLV >100 >15
9 Ac-K-@E-SLV 0.32 6 0.01 0.05
21 and
23 positions
10 Ac-K-@E-S-@L-V 1.0 6 0.1 0.16
Binding to purified a1-syntrophin PDZ domain was assayed in
50 mM HEPES buffer (pH 7.5), 50 mM NaCl at 25C in competition
with a dansylated peptide (Dns-SIESDV, Kd = 2.1 6 0.1 mM [9]). Dis-
sociation constants greater than 100 mM were not adequately de-
fined by this assay and thus are reported as a lower limit. Dissocia-
tion constants%1 mM were calculated by a modified mathematical
analysis to remove the assumption that competitor ligand is always
in large excess relative to the fluorescent ligand or protein used in
the assay (see Supplemental Data).
a Syntheses of peptides and unsubstituted @-tides were performed
on solid support following procedures described previously [21].
The substituted @-tides were synthesized as shown in Figure 2
and detailed in the Supplemental Data.
b The dissociation constants for the peptidomimetics were deter-
mined relative to that measured concurrently for the peptide Ac-
KESLV and normalized to the average Kd value of the latter. The dis-
sociation constant determined for the pentapeptide Ac-KESLV is
similar to those reported for longer, nonacetylated peptides with
the same C-terminal sequence [8, 9].
c This compound incorporates the D-enantiomer of the @Leu unit.domimetics can be rationalized from the bound confor-
mation of GVKESLV as determined by NMR [8]. Whereas
the Glu residue binds in an extended conformation, with
a dihedral angle between the Lys and Glu carbonyls of
164 in the most representative of the NMR structure
(model 1 from PDB entry 2pdz), the Leu backbone is
twisted, with the corresponding dihedral angle of the
Ser and Leu carbonyls of 129 (Figure 1B). However,
even at the leucine position, where the preferred confor-
mation of the peptide deviates from the extended con-
formation, substitution with the aza-@-unit is tolerated.
Only incorporation of the stereoisomeric @
DLeu analog
at this position leads to full disruption of binding (entry 5).
The substituted @-tide peptidomimetics are more ef-
fective as PDZ ligands than the corresponding unsubsti-
tuted analogs (e.g., entries 4 and 8), which confirms that
both hydrogen bonding and side chain-side chain inter-
actions are critical to successful b strand mimicry. When
both the Leu and Glu residues are replaced with
substituted aza-@-units (Ac-K@ES@LV), a modest syner-
gistic effect is observed; that is, there is less tolerance
for substitution with the @Leu moiety at the 21 position
when @Glu replaces the glutamate at 23 (compare entry
1 versus entry 6 with entry 9 versus entry 10). Subopti-
mal interactions of the @Leu unit are presumably accom-
modated less easily when the @Glu moiety anchors the
ligand more firmly in the binding cleft [28].
Significance
With a Kd value of 0.32 mM, Ac-K@
ESLV is bound more
tightly to the a1-syntrophin PDZ domain than one of its
extensively studied protein ligands, nNOS; the disso-
ciation constant for this protein is 0.61 mM [9], al-
though it contacts the PDZ domain over a greater sur-
face area than the peptidomimetic and with additional
residues in the interfacial b strand [24]. Indeed, Ac-
K@ESLV is one of the most tightly bound small-mole-
cule ligands reported for any PDZ domain. The highest
affinity PDZ ligand of which we are aware is WETWV,
selected as a ligand for the Erbin PDZ domain by
phage display; Skelton et al. report an IC50 value of
0.020 mM for this peptide from a bead-based fluores-
cence assay [29]. Although the doubly substituted
analog Ac-K@ES@LV is slightly weaker than Ac-
K@ESLV, it is nonetheless more tightly bound than
the parent peptide from which it was designed. Be-
cause of the ability of the aza-@-unit to mimic an ex-
tended peptide residue in conformation, side chain
functionality, and hydrogen bonding along one edge,
and because of the resistance of oligomeric @-tides
to proteolysis, they show considerable promise as b
strand peptidomimetics. Substitution of selected resi-
dues in extended peptides with the corresponding
aza-@-units is a strategy for enhancing binding affin-
ity that may be applied to ligands for other PDZ do-
mains and to a variety of protein-protein interactions
mediated by b strand association.
Supplemental Data
Supplemental Data include general materials and methods; prote-
ase assays; synthesis of Cbz-@Glu(OtBu) monothioimide; synthesis
of Ac-K@ES@LV, 10; characterization data for other assayed
compounds; and the ‘‘no assumptions’’ method for calculating
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1251dissociation constants. They are available at http://www.chembiol.
com/cgi/content/full/13/12/1247/DC1/.
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